FXYD3 and neoplasm: FXYD3 is overexpressed in various tumours including human breast cancer [8], bladder cancer [9], prostate carcinoma [10], rectal cancer [11], gastric adenocarcinoma [12], intrahepatic cholangiocarcinoma [13] and hepatocellular carcinoma [14].